2024 |
Vigil Neuroscience Inc
|
President, Chief Executive Officer and Director |
- |
- |
2024 |
Quanterix Corp
|
Director |
- |
- |
2024 |
Acrivon Therapeutics Inc
|
Director |
- |
- |
2023 |
Aeglea BioTherapeutics Inc
|
Independent Director |
- |
- |
2023 |
Acrivon Therapeutics Inc
|
Independent Director |
- |
- |
2022 |
Absci Corp
|
Chairman of the Board |
203.3 K |
-77.3 % |
2022 |
Aeglea BioTherapeutics Inc
|
Independent Director |
78.8 K |
- |
2022 |
Spyre Therapeutics Inc.
|
- |
78.8 K |
-67.5 % |
2022 |
Vigil Neuroscience Inc
|
President, Chief Executive Officer and Director |
- |
- |
2021 |
Absci Corp
|
Chairman of the Board |
897.4 K |
5284.4 % |
2021 |
Spyre Therapeutics Inc.
|
Independent Director |
242.0 K |
15.6 % |
2021 |
Vigil Neuroscience Inc
|
President, Chief Executive Officer and Director |
- |
- |
2020 |
Spyre Therapeutics Inc.
|
Independent Director |
209.3 K |
114.0 % |
2020 |
Absci Corp
|
Independent Director |
16.7 K |
- |
2019 |
Spyre Therapeutics Inc.
|
Independent Director |
97.8 K |
-68.8 % |
2018 |
Spyre Therapeutics Inc.
|
Independent Director |
313.5 K |
- |
2017 |
Spyre Therapeutics Inc.
|
Independent Director |
- |
- |